BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 11, 2004
View Archived Issues
U.K. approval for Striant SR
Read More
CyDex allows Gilead use of Captisol technology for early clinical study
Read More
Biosite enters discovery collaboration with DMI BioSciences
Read More
Bionomics anticancer IP advances into drug discovery
Read More
Progression of gene vector manufacturing for GeneMax TAP cancer vaccine
Read More
SYN X reacquires rights to Alzheimer's diagnostic technology
Read More
Solvay reports favorable development of R&D portfolio
Read More
Antibacterial efficacy of oritavancin
Read More
Antibacterial effects of daptomycin in patients with cSSSI
Read More
Vertex highlights 2003 developments
Read More
Procter & Gamble present data on novel MMP inhibitor, PG-530742, at ACC
Read More
Tyrosine kinase receptor inhibitor prevents restenosis after coronary stenting in porcine model
Read More
New anti-TACI receptor antibodies and their use reported by Genentech
Read More
Pfizer describes inhibitors of CDKs and tyrosine kinases and their therapeutic use
Read More
Novel cathepsin K inhibitors prepared and tested by Korean researchers
Read More
Nippon Shinyaku scientists discover Bcr-Abl kinase inhibitors for use in leukemia therapy
Read More
Novel LXR agonists identified by Merck researchers
Read More
New hypoglycemic and hypolipidemic agents claimed by Bayer
Read More
NitroMed presents novel COX-2 inhibitors in a recent patent
Read More
Kyowa Hakko scientists develop PDE10A inhibitors for Parkinson's disease and other uses
Read More
Schering plans introduction of new drugs in coming years
Read More
Orphan drug status for AT-1001 for Fabry's disease
Read More
BioTie Therapies and Aventis sign agreement for new heparin-like drug
Read More
Positive results from Xibrom phase III studies
Read More
CE Mark for Durolane for osteoarthritis of the hip joint
Read More
Phase II study for MT-201 in breast cancer
Read More
New phase I/IIa study to evaluate Telcyta combination therapy for NSCLC
Read More
FDA approval for Sensipar
Read More
Patient enrollment completed for a phase IV trial with Spiriva
Read More
Antiarrhythmic effects of ranolazine in isolated myocytes
Read More
Antiinflammatory effects induced by AGI-1067 in atherosclerosis
Read More
New data on the antihypertensive efficacy of the renin inhibitor aliskiren
Read More